These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 18389905

  • 1. In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide.
    Duan M, Zhou Z, Lin RX, Yang J, Xia XZ, Wang SQ.
    Antivir Ther; 2008; 13(1):109-14. PubMed ID: 18389905
    [Abstract] [Full Text] [Related]

  • 2. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H, Jin M, Yu Z, Xu X, Peng Y, Wu H, Liu J, Liu H, Cao S, Chen H.
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [Abstract] [Full Text] [Related]

  • 3. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
    Lu J, Guo Z, Pan X, Wang G, Zhang D, Li Y, Tan B, Ouyang L, Yu X.
    Respir Res; 2006 Mar 23; 7(1):43. PubMed ID: 16553963
    [Abstract] [Full Text] [Related]

  • 4. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 23; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-influenza-virus activity of total alkaloids from Commelina communis L.
    Bing FH, Liu J, Li Z, Zhang GB, Liao YF, Li J, Dong CY.
    Arch Virol; 2009 Dec 23; 154(11):1837-40. PubMed ID: 19774337
    [Abstract] [Full Text] [Related]

  • 7. Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system.
    Zhang T, Zhao PS, Zhang W, Liang M, Gao YW, Yang ST, Wang TC, Qin C, Wang CY, Xia XZ.
    Vaccine; 2011 Feb 11; 29(8):1558-64. PubMed ID: 21215341
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
    Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF.
    Antiviral Res; 2005 Oct 11; 68(1):10-7. PubMed ID: 16087250
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of TheraMax on influenza virus infections in cell culture and in mice.
    Smee DF, Hurst BL, Wong MH.
    Antivir Chem Chemother; 2011 Jul 04; 21(6):231-7. PubMed ID: 21730370
    [Abstract] [Full Text] [Related]

  • 16. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O.
    Antiviral Res; 2011 Sep 04; 91(3):304-13. PubMed ID: 21777621
    [Abstract] [Full Text] [Related]

  • 17. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
    Price GE, Soboleski MR, Lo CY, Misplon JA, Pappas C, Houser KV, Tumpey TM, Epstein SL.
    Vaccine; 2009 Nov 05; 27(47):6512-21. PubMed ID: 19729082
    [Abstract] [Full Text] [Related]

  • 18. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, Büttner M, Planz O.
    Vaccine; 2008 Dec 09; 26(52):6965-74. PubMed ID: 18848593
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.